Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Psoriasis can cause temporary or permanent hair loss.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

The document explains how to identify different hair problems using a microscope.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

A patient with a skin condition had unusual scarring hair loss but improved with treatment.

A one-year-old child with a genetic condition had symptoms improved by treating zinc deficiency.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Diagnosing mycosis fungoides, a rare skin cancer, is difficult in elderly adults and requires careful examination to avoid mistaking it for less serious skin conditions.

Blocking miR-27a increases sheep hair follicle stem cell growth and decreases cell death, which could help improve wool quality and treat hair loss.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Chemical hair straighteners can cause scalp and hair damage, but long-term effects are unclear.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.

Severe hypothyroidism can cause unusual skin problems that improve with thyroid treatment.

Sodium valproate can worsen psoriasis-like skin conditions.

An adult had a rare scalp infection in the forehead area, treated successfully with itraconazole.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Some drugs for inflammation may cause psoriasis-like hair loss.

Finasteride can cause rare but serious skin rashes.

Metformin is effective for various skin disorders but may cause skin side effects.

Some children with methylmalonic and propionic acidaemias have skin problems related to their condition and diet.